Combination Study With Eftilagimod Alpha (a Soluble LAG-3 Fusion Protein) and Pembrolizumab in Patients With Recurrent or Metastatic HNSCC

Institute of Cancer Science - Beatson West of Scotland Cancer Centre, Glasgow

Rigshospitalet, Copenhagen

Macquarie University Hospital, Macquarie Park

Antwerp University Hospital, Edegem

Herlev Hospital, Herlev

Centre Hospitalier Universitaire (CHU) de Liege, Liège

AZ Sint-Jan Brugge, Bruges

AZ Nikolaas, Sint-Niklaas

Institut Català d'Oncologia - Hospital Universitari de Girona, Girona

Hospital Universitario Lucus Augusti, Lugo

Hospital Universitario Ramón y Cajal, Madrid

START Madrid (Hospital Universitario Fundación Jiménez Díaz), Madrid

Hospital 12 Octubre, Madrid

University of Alabama at Birmingham (UAB) - O'Neal Cancer Center, Birmingham

University Hospital Essen, Essen

Hospital Universitario Miguel Servet, Zaragoza

Universitätsklinikum Bonn, Bonn

Washington University School of Medicine, St Louis

Nationales Centrum für Tumorerkrankungen Heidelberg, Heidelberg

Oncology Consultants, Houston

Universitätsklinikum Ulm, Ulm

"The Oncology Institute Prof Dr Ion Chiricuta I.O.C.N.", Cluj-Napoca

Vall d'Hebron Institute of Oncology (VHIO), Barcelona

Hospital de la Santa Creu i de Sant Pau, Barcelona

Arensia Exploratory Medicine Llc, Kapitanivka

University College London Hospitals NHS Foundation - The Harley Street Clinic, London

The Christie NHS Foundation Trust, Manchester

Nottingham University Hospitals, NHS Trust, Nottingham